SEC Form 4 · accession 0001140361-15-036229
HEALTHEQUITY, INC. · HQY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Manu S Rana
Director
Period of report
Sep 25, 2015
Accepted (ET)
Sep 29, 2015 · 8:37 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001428336
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Sep 25, 2015 | S | 1,150,000 | $29.50 | D | 1,676,468 | I | See footnote |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F3,F4 | $1.25 | holding | — | — | — | — | Oct 25, 2021 | Common Stock | 7,500 | 7,500 | D |
| Stock Option (right to buy)F3,F4 | $1.25 | holding | — | — | — | — | Apr 26, 2022 | Common Stock | 15,000 | 15,000 | D |
| Stock Option (right to buy)F5,F4 | $1.50 | holding | — | — | — | — | May 9, 2023 | Common Stock | 15,000 | 15,000 | D |
| Stock Option (right to buy) | $14.00 | holding | — | — | — | Jan 31, 2015 | Jul 30, 2024 | Common Stock | 15,000 | 15,000 | D |
| Stock Option (right to buy)F6 | $25.39 | holding | — | — | — | — | Mar 26, 2025 | Common Stock | 15,000 | 15,000 | D |
Explanation of responses
- F1Price of $29.50 does not reflect underwriter discount or fees.
- F2All securities are held of record by Financial Partners Fund I, L.P. ("FPF I"), a Delaware limited partnership. The reporting person is a managing principal of FPF I. The reporting person disclaims beneficial ownership of the securities held by FPF I except to the extent of his pecuniary interest therein.
- F3As previously reported in the reporting person's Form 3, the option grant had a $2.25 exercise price upon issuance. The $2.25 exercise price was automatically adjusted to $1.25 on August 4, 2014 as a result of the occurrence of an event specified in the terms of the option grant at the time of its issuance.
- F4The option is immediately exercisable.
- F5As previously reported in the reporting person's Form 3, the option grant had a $2.50 exercise price upon issuance. The $2.50 exercise price was automatically adjusted to $1.50 on August 4, 2014 as a result of the occurrence of an event specified in the terms of the option grant at the time of its issuance.
- F6The option became exercisable as to 7,500 shares upon the reporting person's reelection to the issuer's board of directors at the issuer's 2015 Annual Meeting of Stockholders held on June 24, 2015. The remaining 7,500 shares will become exercisable on January 31, 2016; provided, that the reporting person continues to serve as a director of the issuer through such date.